Shunbun Kita

Title: Shunbun Kita: Innovator in Biopharmaceuticals

Introduction

Shunbun Kita is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that interact with apolipoprotein A-I. His work aims to advance medical treatments for diseases associated with cubulin.

Latest Patents

Shunbun Kita holds a patent for a polypeptide and its DNA. This invention is designed to create a screening method for identifying compounds that can bind to apolipoprotein A-I. The goal is to promote or inhibit the binding of a cubulin fragment to apolipoprotein A-I. The compounds discovered through this screening method can be utilized in preventives and remedies for various diseases in which cubulin is involved.

Career Highlights

Kita is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda focuses on innovative solutions that address critical health challenges. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.

Collaborations

Shunbun Kita collaborates with various professionals in his field, including his coworker Yoshio Taniyama. Their combined expertise enhances the research and development efforts at Takeda.

Conclusion

Shunbun Kita's innovative work in biopharmaceuticals exemplifies the impact of scientific research on healthcare. His contributions are paving the way for new treatments that could significantly improve patient outcomes.